Brief: Opyl Signs Agreements With Netherlands-Based Cardialysis And UK-Based Evestia Clinical
12/06/2025 02:47
June 12 (Reuters) - Opyl Ltd OPL.AX: SIGNING AGREEMENTS WITH NETHERLANDS-BASED CARDIALYSIS AND UK-BASED EVESTIA CLINICAL COLLABORATIONS FOR ITS AI-ENABLED CLINICAL TRIAL DESIGN PLATFORM, TRIALKEY.AI Source text: ID:nASX3YMslR Further company coverage: OPL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pathkey.AI
See all newsBrief: Pathkey.Ai Posts FY Loss After Tax Of A$3.7 Million
Brief: Pathkey.Ai Announces A$2.8 Million Placement
Brief: Pathkey.AI Seeks Trading Halt Pending Capital Raising Announcement
Brief: Pathkey.AI Appoints Andrew Farnsworth As CEO
Australia's Pathkey.AI soars on deal to buy semiconductor developer